pill version of semaglutide Novo Nordisk's weight-loss wins FDA approval Novo Nordisk to Seek Approval

Primary result at 15 mg: 22.5% mean body-weight reduction vs

It's worth noting that this is not a replacement for volume: while it tones muscles and improves skin elasticity, it cannot replace lost fat volume in the face, and it's important to use a conductive gel to facilitate the impact

If obesity causes both type 2 diabetes and hypothyroidism, treating the obesity with semaglutide to lose weight could help reduce the impact or even "cure" both hypothyroidism and diabetes while addressing obesity

This drug, approved for chronic weight management, is prescribed for adults and adolescents aged 12 and older with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related health condition